Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective Cohort Study to Explore Biomarkers for Response to Neoadjuvant Chemoimmunotherapy in Stage II-III Non-small Cell Lung Cancer

NCT06907160 is registered in ClinicalTrials.gov with Yonsei University as lead sponsor.

NCT NCT06907160
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06907160 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective Cohort Study to Explore Biomarkers for Response to Neoadjuvant Chemoimmunotherapy in Stage II-III Non-small Cell Lung Cancer
Lead sponsor
Yonsei University
Phase
Observational
Overall status
Recruiting
Start date
August 7, 2024
Completion date
June 30, 2029
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

clinical stage ii to iii non-small cell lung cancer